QurCan therapeutics is a biotech company developing next-generation chemo and gene therapies using its proprietary nanoparticle platform. The platform technology enables antibody-guided targeting and active transportation across the blood-brain barrier, with broad payload flexibility (siRNA/mRNA, peptides, chemo agents). The company's lead asset is a first-in-class therapeutic agent on the cusp of IND that can modify the tumour microenvironment and turn cold tumours hot.

QurCan logo



Event details

Date: September 21 - 23, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


10 in total